Revvity | PKI - Equity Capital And Reserves



Revvity reported $7.64B in Equity Capital and Reserves for its fiscal quarter ending in March of 2025.


Equity Capital And Reserves Change Date
Adcock Ingram Holdings ZAR 5.54B 131.19M Dec/2024
Agilent USD 6.37B 234M Jul/2025
Align Technology USD 3.79B 57.74M Mar/2025
Bio Techne USD 1.92B 99.22M Jun/2025
Bio-Rad Laboratories USD 7.13B 449.3M Jun/2025
Bruker USD 1.87B 33.9M Jun/2025
Celltrion KRW 17.14T 298.25B Mar/2025
Charles River Laboratories USD 3.31B 119.03M Jun/2025
Cspc Pharmaceutical CNY 32.26B 2.59B Dec/2024
Danaher USD 52.33B 1.48B Jun/2025
Dentsply International USD 1.96B 50M Jun/2025
Dianthus Therapeutics USD 303.08M 49.4M Jun/2025
Divis Laboratories Ltd 149.69B 12.52B Mar/2025
Edwards Lifesciences USD 10.19B 193.2M Mar/2025
Exact Sciences USD 2.47B 72.51M Jun/2025
Hologic USD 4.84B 223.8M Jun/2025
Illumina USD 2.26B 110M Jun/2025
Intuitive Surgical USD 17.95B 745.4M Jun/2025
IQVIA Holdings USD 5.78B 199M Jun/2025
Kangmei Pharma CNY 7.73B 546.26M Jun/2025
Knight Therapeutics CAD 773.91M 11.11M Sep/2024
Laboratorios Farma EUR 574.72M 6.82M Jun/2025
Laboratory Of America USD 8.47B 151M Jun/2025
Malin Corporation EUR 193.2M 75M Dec/2024
Medical Developments International AUD 55.33M 9.6M Dec/2024
Mettler Toledo International USD -258793000 76.81M Jun/2025
Myriad Genetics USD 704.9M 3.8M Mar/2025
Neuren Pharmaceuticals AUD 363.9M 144.75M Dec/2024
Organigram Holdings CAD 385.5M 61.85M Jun/2025
Pharma Mar EUR 201.53M 4.06M Jun/2025
Qiagen NV USD 3.51B 97.61M Jun/2025
Quest Diagnostics USD 7.23B 299M Jun/2025
Quidel USD 2.79B 204.5M Jun/2025
Repligen USD 1.99B 12.76M Mar/2025
Revvity USD 7.64B 29.74M Mar/2025
Sartorius EUR 2.66B 51.3M Jun/2025
Sino Biopharmaceutical CNY 31.96B 884.2M Dec/2024
Thermo Fisher Scientific USD 49.36B 227M Mar/2025
Tilray USD 3.47B 5.16M Nov/2024
Waters USD 2.16B 197.42M Jun/2025
Zz Pientze Pharmaceu 14.65B 617.48M Jun/2025